作者: Fatah Kashanchi
DOI:
关键词:
摘要: The present invention is directed to a process for inhibiting the replication of human immunodeficiency virus-1 (HIV-1), by contacting cell with at least one compound according Formula I. substituent groups R1, R2, R3, X, Y, Z, A and B are as defined above. Also contemplated method treating or preventing HIV-1 infection in subject, administering therapeutically effective amount I, well modulating activity cyclin dependent kinase (cdk) infected using I compound.